Ruel Jacob wrote a new post 1 week, 3 days ago
Join our Young CRC Patient Focus Group
This year, DiCE is working on gaining additional insight into the experiences of young colorectal cancer patients, from symptoms to diagnosis to […]
Ruel Jacob wrote a new post 1 week, 4 days ago
Shaping Priorities for the EU4Health Funding Programme
The Commission conducted in May a targeted consultation on the EU4Health programme’s future priorities, orientation, and needs. DiCE contributed […]
Ruel Jacob wrote a new post 1 week, 5 days ago
Croatian National Policy Event on Digestive Cancers
On 25 May 2023, Iget, our Croatian member, organised a successful National Policy Event in Zagreb, Croatia. […]Ruel Jacob wrote a new post 1 month, 1 week ago
SURVEY: Assessing AI Awareness & Perceptions Among Patient Organisations
European Patient’s Forum (EPF) is collecting responses to a survey addressed to patients’ organisations or individuals carrying out patient advocacy […]
Ruel Jacob wrote a new post 1 month, 2 weeks ago
Kick-Off Event for the SmartCARE Project
On 28 March, key collaborators from the smartCARE consortium gathered in Brussels to share ideas and […]Ruel Jacob wrote a new post 1 month, 2 weeks ago
A Wind of Change in the EU's Pharmaceutical Landscape
The challenge that the European Commission set itself up for in revising the EU’s Pharmaceutical Legislation (namely Directive 2001/83/EC1 and […]
Ruel Jacob wrote a new post 1 month, 2 weeks ago
Colores Finland Shares Effort to Support People Living with Lynch Syndrome
Lynch Syndrome impacts several areas of life. Patients can benefit from collaboration with specialists across […]Ruel Jacob wrote a new post 1 month, 2 weeks ago
EuropaColon Poland Received "Swallow of Hope Award"
Congratulations to our member organisation EuropaColon Poland Foundation for Patients, on receiving the “Swallow of Hope”, a national Polish awa […]
Ruel Jacob wrote a new post 1 month, 2 weeks ago
TOGAS: Towards Gastric Cancer Screening Implementation in the European Union
On 30 – 31 March, DiCE participated in the kick-off meeting of the TOGAS project held in Riga, […]Ruel Jacob wrote a new post 1 month, 2 weeks ago
Liver Cancer Index – The Mapping Survey Is Available Online
The survey was created to map the liver cancer treatment landscape across the EU and is now available online and disseminated among several relevant […]
Ruel Jacob wrote a new post 1 month, 2 weeks ago
Scientists Propose A Novel Approach For The Treatment Of Liver Cancer
The Nature Cancer journal recently published promising results from cell and mouse studies by liver cancer specialists at the Massachusetts General […]
Ruel Jacob wrote a new post 1 month, 2 weeks ago
EuropaColon Slovenia Celebrates Its 15th Anniversary
This March EuropaColon Slovenia rang in its 15th anniversary as a patient association! EC Slovenia was an original member of EuropaColon, the […]
Ruel Jacob wrote a new post 2 months, 2 weeks ago
Primary Findings From The GLOW Study Signals Positive Momentum In The Development Of Novel Therapeutic Options For Patients With HER2-Negative Locally Advanced Unresectable Or Metastatic Gastric & GEJ Cancers
At the end of 2022, leaders of the Phase 3 clinical trial GLOW shared their positive primary findings. GLOW (NCT03653507) is a global, multicenter, […]
Ruel Jacob wrote a new post 2 months, 2 weeks ago
Trastuzumab Deruxtecan Meets Objective Response Rate Endpoint in Several Types of HER2-expressing Advanced Solid Tumours
Positive topline results of the ongoing DESTINY-PanTumour02 Phase II trial (NCT04482309) showed that treatment with trastuzumab deruxtecan met the […]
Ruel Jacob wrote a new post 2 months, 2 weeks ago
The First International Management Guidelines for Early-Onset Colorectal Cancer
This March, the Clinical Gastroenterology and Hepatology journal published the first management guidelines for Early-Onset Colorectal Cancer […]
Ruel Jacob wrote a new post 2 months, 2 weeks ago
FAPA – Familial Adenomatous Polyposis Association rang in 30 years as a scientific and patient organisation with […]Ruel Jacob wrote a new post 3 months ago
Imfinzi & Imjudo Immunotherapy Drug Combinations Approved in the EU for the Treatment of Advanced Liver Cancer
The combination of durvalumab (Imfinzi) and tremelimumab (Imjudo) immunotherapies has been approved by the […]Ruel Jacob wrote a new post 3 months, 2 weeks ago
Zolbetuximab Plus Chemotherapy Extends Overall Survival for Patients with Advanced or Metastatic Gastric & Gastro-oesophageal Junction Adenocarcinoma
The Annual American Society of Clinical Oncologists Gastrointestinal Cancers Symposium (ASCO GI) kicked off the year with lots of new data in the […]
Ruel Jacob wrote a new post 4 months, 3 weeks ago
<strong>First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer</strong>
On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first […]
Ruel Jacob wrote a new post 4 months, 3 weeks ago
<strong>Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer</strong>
On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin) […]
- Load More